Urinary bladder cancer is among the five most common malignancies worldwide. While early detection and treatment dramatically increases a patient’s chance of survival, existing urinalysis test has serious limitations.
Thus, scientists look forward to the development of a non-invasive urinalysis assays via reliable diagnostic markers that will surely benefit patients at risk and/ or suffering the condition.
A team from University of Florida and University of Michigan, headed by Steve Goodison may already have what the experts are looking for.
The researchers have moved toward that goal by identifying potential biomarkers for bladder cancer, including a protein present in the urine of …read more